APSNZPS_2018_logoBThe 2018 program includes 6 sponsored sessions over 2 days.

Find out more below and join us at one or more of the sponsored sessions this April.

Mundipharma
Monday 9 April, 7.15 – 8.15am – includes breakfast
Opioid Prescribing – Getting the Balance Right

The use of opioids in the treatment of chronic non-cancer pain is a topic of much debate. When not optimally managed, prescribing opioids can result in escalating doses, poor patient outcomes and unsanctioned use. In this symposium chaired by Dr Tim Semple, three experts in their fields, Dr Mark Hardy, A/Professor Malcolm Hogg and A/Professor Peter Gonski will outline how they use opioids in carefully selected patients, minimising the potential risks and ultimately improving patient outcomes.

Pierre Fabre
Monday 9 April, 7.15 – 8.15am – includes breakfast
Practical management strategies in Fibromyalgia Syndrome

It estimated that between 2 and 5% of people in developed countries have fibromyalgia, a chronic centralized pain condition characterised by widespread pain, poor unrefreshing sleep and fatigue. Dr Michael Vagg will be presenting on the management of fibromyalgia in his clinical practice, focusing on the practical side of managing fibromyalgia patients, what strategies are employed in his practice, Pain Matrix, and how he is using a combination of strategies to improve patients’ quality of life.

Indivior
Monday 9 April, 5.15 – 6.15pm – includes canapes and drinks
Transitional Pain Medicine: Improving Peri-Hospital Care as a model for long-term change in pain management and opioid prescribing

With the current concern about opioid prescribing and opioid dependence, the postsurgical period remains a critical window with the risk of significant opioid dose escalation, particularly in patients with a history of chronic pain and pre-surgical opioid use. Dr Hance Clarke will discuss the development and implementation of a Transitional Pain Program that enables close monitoring of pain, opioid medications and mental health vulnerabilities that place certain patients at a higher risk of developing chronic postsurgical pain and progressing to dependence.

iX Biopharma
Monday 9 April, 5.15 – 6.15pm – includes canapes and drinks
Ketamine and buprenorphine – old analgesics in a novel sublingual formulation

Ketamine is being used extensively in pain management, however, its optimal use remains to be determined. The clinical scenarios in which ketamine can be given are constrained by the only licensed formulations being an injection. Dr Janakan Krishnarajah will discuss clinical use cases for sublingual ketamine and sublingual buprenorphine. He will also provide an update on the clinical development and latest clinical trial data for Wafermine™ and Bnox™ sublingual wafers.

BioElectronics
Tuesday 10 April, 7.30 – 8.30am – includes breakfast
ActiPatch: wearable, paraesthesia-free, neuromodulation for chronic pain relief

Chronic musculoskeletal pain is prevalent in Australia/New Zealand and presents significant socio-economic challenges.  Chronic pain can be complex to manage since the level of pain is often unrelated to the level of underlying tissue damage.
Dr Sree N. Koneru leads new product development at BioElectronics, with an emphasis on prototype development and validation of efficacy through pilot clinical studies. Learn how ActiPatch uses high-frequency electromagnetic waves to regulate afferent nerve activity and mitigate nerve hypersensitivity.  

Seqirus
Tuesday 10 April, 7.30 – 8.30am – includes breakfast
Analgesic properties of atypical opioids: the concept and role of ‘μ load’

This session will deliver a comprehensive explanation of the difference between analgesic and opioid equivalence in pain management and will discuss the role of  ‘µ load’ in strong analgesics and the effects of MOR activity on efficacy and tolerability. Prof Ralf Baron will also discuss the atypical opioid Tapentadol, the molecule’s mode of action and describe how Tapentadol immediate release and sustained release fits into his practice by sharing his clinical experience.

Register today!

APSNZPS_2018_logoA_details

About Australian Pain Society

The Australian Pain Society is a multidisciplinary body aiming to relieve pain and related suffering through leadership in clinical practice, education, research and public advocacy.

Replies

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s